Table 1.
CTC Isolation Technique | Method | Advantages | Disadvantages | |
---|---|---|---|---|
Label dependent isolation | Antibody conjugation to magnetic nanoparticles | Antibody linked to magnetic nanoparticles to isolate CTCs expressing specific marker | One assay with FDA approval; can use different antibodies to isolate different populations of cells | Low sensitivity; down-regulation of EpCAM markers during metastatic transformation can limit sensitivity |
Microfluidics | Controlled flow in microchip to enhance CTC binding to antibody coated microchip walls | High sensitivity with high cell viability | Only able to process small sample volumes | |
Label independent isolation | Filtration | Size-based separation with purification to isolate CTCs from other blood cells | Isolation regardless of surface marker expression | Requires large volumes; poor purity; pore clogging |
Microfluidics (not dependent on antibodies) | Flow through microchip to separate CTCs based on geometric properties | High sensitivity with high cell viability | Only able to process small sample volumes | |
Density gradient separation | Centrifugation to separate CTCs from blood cells based on density | Efficient process; cell viability after isolation | Loss of cells (varying density when cells clump); often requires further isolation due to contamination with other blood cells | |
Imaging | Fiber optic array laser scanning to visually detect CTCs | Enumeration of CTCs | Lacking precision | |
Dielectrophoresis | Application of non-uniform electric field to isolate cells | High recovery rate and viability | Low purity of the isolated sample | |
Inertial focusing | Fluid inertia at high flow rates to isolate cell populations | Recovery of viable cells | Requirement of pre-processing of sample |
Abbreviations: CTC: circulating tumor cell; EpCAM: epithelial cell adhesion molecule.